{{Rsnum
|rsid=363227
|Gene=SLC18A2
|Chromosome=10
|position=119026566
|Orientation=plus
|GMAF=0.2498
|Gene_s=SLC18A2
|Assembly=GRCh37.p10
|GenomeBuild=37.5
|dbSNPBuild=138
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 79.6 | 18.6 | 1.8
| HCB | 38.7 | 45.3 | 16.1
| JPT | 38.1 | 42.5 | 19.5
| YRI | 44.2 | 46.3 | 9.5
| ASW | 49.1 | 45.6 | 5.3
| CHB | 38.7 | 45.3 | 16.1
| CHD | 33.0 | 49.5 | 17.4
| GIH | 54.5 | 38.6 | 6.9
| LWK | 46.4 | 41.8 | 11.8
| MEX | 53.4 | 37.9 | 8.6
| MKK | 64.1 | 26.3 | 9.6
| TSI | 77.5 | 20.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22532702
|Title=Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition
}}

{{PMID Auto
|PMID=18180394
|Title=Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans.
|OA=1
}}

{{PMID Auto
|PMID=18316816
|Title=Experimenting with spirituality: analyzing The God Gene in a nonmajors laboratory course.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}